Cargando…
Increased Risk for Severe Malaria in HIV-1–infected Adults, Zambia
To determine whether HIV-1 infection and HIV-1–related immunosuppression were risk factors for severe malaria in adults with some immunity to malaria, we conducted a case–control study in Luanshya, Zambia, during December 2005–March 2007. For each case-patient with severe malaria, we selected 2 matc...
Autores principales: | Chalwe, Victor, Mukwamataba, Doreen, Menten, Joris, Kamalamba, John, Mulenga, Modest, D’Alessandro, Umberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687012/ https://www.ncbi.nlm.nih.gov/pubmed/19402961 http://dx.doi.org/10.3201/eid1505.081009 |
Ejemplares similares
-
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children
por: Nambozi, Michael, et al.
Publicado: (2011) -
Defining the malaria burden in Nchelenge District, northern Zambia using the World Health Organization malaria indicators survey
por: Nambozi, Michael, et al.
Publicado: (2014) -
Safety and efficacy of lumefantrine-artemether (Coartem(®)) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults
por: Mulenga, Modest, et al.
Publicado: (2006) -
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria
por: Nambozi, Michael, et al.
Publicado: (2017) -
The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia
por: Van Geertruyden, Jean-Pierre, et al.
Publicado: (2009)